| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/15/2004 | CA2500472A1 Genes and polypeptides relating to human pancreatic cancers |
| 04/15/2004 | CA2500470A1 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | CA2500433A1 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/15/2004 | CA2500413A1 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 04/15/2004 | CA2500405A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | CA2500401A1 Antigenic peptides |
| 04/15/2004 | CA2500288A1 Crystal structure of erbb2 and uses thereof |
| 04/15/2004 | CA2500278A1 Pharmaceutical preparation for hearing impairment |
| 04/15/2004 | CA2500093A1 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
| 04/15/2004 | CA2499871A1 Orthopoxvirus vectors, genes and products thereof |
| 04/15/2004 | CA2499837A1 Human papillomavirus polypeptides and immunogenic compositions |
| 04/15/2004 | CA2499483A1 Novel chemokine-like polypeptides |
| 04/15/2004 | CA2499458A1 Protein s protects the nervous system from injury |
| 04/15/2004 | CA2499123A1 Ii-key/antigenic epitope hybrid peptide vaccines |
| 04/15/2004 | CA2498854A1 Novel mhc ii associated peptides |
| 04/15/2004 | CA2498829A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 04/15/2004 | CA2498631A1 Use of a33 antigens and jam-it |
| 04/15/2004 | CA2487206A1 P53 binding polypeptide |
| 04/15/2004 | CA2484335A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 04/14/2004 | EP1408334A1 Procalcitonin 3-116 |
| 04/14/2004 | EP1408333A2 Diagnosis and treatment of Alzheimer's disease |
| 04/14/2004 | EP1408114A1 Modular antigen-transporter-molecules (MAT-molecules) for modulating immune responses, corresponding constructs and methods and uses thereof |
| 04/14/2004 | EP1408050A1 A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue |
| 04/14/2004 | EP1408049A2 A novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator |
| 04/14/2004 | EP1407781A1 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 04/14/2004 | EP1407779A1 Use of ghrelin for treating low body weight and body fat in gastrectomized individuals |
| 04/14/2004 | EP1407677A2 Compositions comprising partly-hydrolized fish gelatin and use thereof |
| 04/14/2004 | EP1407273A2 Methods of assessing wolframin protein activity |
| 04/14/2004 | EP1407269A2 A method for diagnosing a person having multiple sclerosis |
| 04/14/2004 | EP1407054A2 Expression system |
| 04/14/2004 | EP1407045A2 Retinoid pathway assays, and compositions therefrom |
| 04/14/2004 | EP1407042A2 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 04/14/2004 | EP1407039A2 Anti-arthropod vector vaccines methods of selecting and uses thereof |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407025A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced male gene |
| 04/14/2004 | EP1407024A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced phoe gene |
| 04/14/2004 | EP1407023A2 Group b streptococcus antigens and corresponding dna fragments |
| 04/14/2004 | EP1407021A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene |
| 04/14/2004 | EP1407020A2 Stress-associated genetic products from ashbya gossypii |
| 04/14/2004 | EP1407019A2 Intestinal proteins |
| 04/14/2004 | EP1407018A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/14/2004 | EP1407017A2 Human tumor necrosis factor receptor |
| 04/14/2004 | EP1407016A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407015A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407014A2 Screening method for attenuating or virulence defective microbial cells |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1407011A2 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
| 04/14/2004 | EP1407008A2 Influenza vaccine composition |
| 04/14/2004 | EP1407007A1 Attenuated circovirus |
| 04/14/2004 | EP1407005A2 Integrative assays for monitoring molecular assembly events |
| 04/14/2004 | EP1406951A1 Keratin-based products and methods for their production |
| 04/14/2004 | EP1406930A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 04/14/2004 | EP1406929A2 Glycoprotein vi fusion proteins |
| 04/14/2004 | EP1406928A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2004 | EP1406927A2 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
| 04/14/2004 | EP1406926A2 Novel neurotrophic factors |
| 04/14/2004 | EP1406925A2 Survivin interacting protein tpr1 |
| 04/14/2004 | EP1406924A2 Oncosuppressive gene |
| 04/14/2004 | EP1406923A2 Histidine phosphatase interacting protein with 180kd |
| 04/14/2004 | EP1406922A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 04/14/2004 | EP1406919A2 Method for electrophoretically separating membrane proteins |
| 04/14/2004 | EP1406918A1 The production of soluble keratin derivatives |
| 04/14/2004 | EP1406917A1 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies |
| 04/14/2004 | EP1406916A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 04/14/2004 | EP1406657A1 A novel engineered superantigen for human therapy |
| 04/14/2004 | EP1406655A2 A modulator of antiestrogen pharmacology |
| 04/14/2004 | EP1406653A2 T cell regulatory genes and methods of use thereof |
| 04/14/2004 | EP1406651A2 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 04/14/2004 | EP1406646A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/14/2004 | EP1406645A2 Novel human transporter proteins and polynucleotides encoding the same |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1406573A2 Conditioned cell culture media and uses thereof |
| 04/14/2004 | EP1406518A2 Modifying nicotine and nitrosamine levels in tobacco |
| 04/14/2004 | EP1406493A1 Administration of agents via the pept-2 transporter |
| 04/14/2004 | EP1406489A2 Eukaryotic genes involved in adult lifespan regulation |
| 04/14/2004 | EP1406484A2 Anti-apoptosis genes and methods of use thereof |
| 04/14/2004 | EP1406483A1 Genes for modifying plant traits iv |
| 04/14/2004 | EP1259617B1 Bunyaviridal reaper proteins and uses therefor |
| 04/14/2004 | EP1257571B1 Method of purifying a hydrophobin present in a hydrophobin-containing solution |
| 04/14/2004 | EP1235854A4 Method of separating prions from biological materials |
| 04/14/2004 | EP1218394A4 Differentially expressed genes associated with her-2/neu overexpression |
| 04/14/2004 | EP1181038B1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 04/14/2004 | EP1121426B1 Method for triggering apoptosis in cells |
| 04/14/2004 | EP1112163B1 Bioriented polyethylene film with a high water vapor transmission rate |
| 04/14/2004 | EP1036185B1 Proteinase inhibitor fusion proteins |
| 04/14/2004 | EP1021541B1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/14/2004 | EP1015490B1 No-modified hemoglobins and uses therefor |
| 04/14/2004 | EP0876493B1 Production of bacillus thuringiensis integrants |
| 04/14/2004 | EP0870044B1 Regulated protein expression in stably transfected mammalian cells |
| 04/14/2004 | EP0729975B1 Ecdn protein and dna coding for the same |
| 04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
| 04/14/2004 | CN1489692A HCV antigen/antibody combination assay |
| 04/14/2004 | CN1489631A ARCELIN-5 promoter and use thereof |
| 04/14/2004 | CN1489630A HIV-like particles and use thereof |
| 04/14/2004 | CN1489628A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489474A Monoclonal antibodies to CLFA protein and method of use in treating or preventing |
| 04/14/2004 | CN1488644A Arabidopsis thaliana BVD1 gene and its use |
| 04/14/2004 | CN1488643A Paddy rice fragile straw controlling gene BC1 and use thereof |
| 04/14/2004 | CN1488642A Paddy rice ethylene receptor protein, coded gene and use thereof |